Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary

What are variant-adapted COVID-19 vaccines?The COVID-19 vaccine developed by BioNTech and Pfizer is known as BNT162b2 (Comirnaty). BNT162b2 contains messenger RNA, or mRNA, from SARS-CoV-2. SARS-CoV-2 is the virus responsible for COVID-19. mRNA is a type of genetic material that contains the instruc...

Full description

Bibliographic Details

Published in:	Expert Review of Vaccines
Main Authors:	Shanti Pather, Alexander Muik, Ruben Rizzi, Federico Mensa
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Subjects:	Plain language summary Vaccines COVID-19 SARS-CoV-2 BNT162b2 Variant of concern
Online Access:	https://www.tandfonline.com/doi/10.1080/14760584.2024.2320858